JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99818

Anti-Human IgG4 pFc’ [HP6023] (Biotin)

Be the first to review this product! Submit a review

|

(3 Publications)

Anti-Human IgG4 pFc’ [HP6023] (Biotin) is a secondary antibody that is suitable for Western blot, IHC, ICC/IF, ELISA and more.

- Reacts with the pFc’ portion of the heavy chain of Human IgG4

View Alternative Names

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

1 Images
ELISA - Anti-Human IgG4 pFc’ [HP6023] (Biotin) (AB99818)
  • ELISA

Supplier Data

ELISA - Anti-Human IgG4 pFc’ [HP6023] (Biotin) (AB99818)

ELISA - Anti-Human IgG4 pFc [HP6023] (Biotin) (ab99818)

ELISA plate was coated with purified human IgG1, IgG2, IgG3, and IgG4.

Immunoglobulins were detected with serially diluted ab99818 followed by Streptavidin-HRP.

Key facts

Host species

Mouse

Target species

Human

Target isotype

IgG4

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

Biotin

Excitation/Emission
Applications

ICC/IF, ELISA, Dot, WB, IHC-Fr

applications

Clonality

Monoclonal

Clone number

HP6023

Isotype

IgG3

Light chain type

kappa

Immunogen

Full Length Protein corresponding to Human IGHG4. The exact immunogen used to generate this antibody is proprietary information.

P01861

Specificity

ab99818 reacts with the pFc’ portion of the heavy chain of Human IgG4.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>for Dot and slot immunoblotting.</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/2000", "notes":"<p></p>" } } }

Product details

This antibody reacts with the pFc' region of Human IgG4

When it comes to advancing your immunohistochemistry (IHC) research, Abcam offers comprehensive suite of IHC kits and secondary antibodies, designed to deliver precise and reliable results.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.1% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store in the dark

Product protocols

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.
See full target information IGHG4

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Antibody therapeutics 6:38-48 PubMed36683766

2023

Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15R complex.

Applications

Unspecified application

Species

Unspecified reactive species

Jihong Chen,Ziyou Shen,Xiaoling Jiang,Zhenzhen Huang,Chongbing Wu,Dongcheng Jiang,Liusong Yin

JCI insight 6: PubMed34582377

2021

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine.

Applications

Unspecified application

Species

Unspecified reactive species

Roland Tschismarov,Raphaël M Zellweger,Min Jie Koh,Yan Shan Leong,Jenny G Low,Eng Eong Ooi,Christian W Mandl,Katrin Ramsauer,Ruklanthi de Alwis

Haemophilia : the official journal of the World Federation of Hemophilia 24:487-491 PubMed29461004

2018

Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.

Applications

Unspecified application

Species

Unspecified reactive species

B Boylan,C H Miller
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com